The year is 2030, you have been in the doctor's office for two hours, answering what seems like hundreds of questions on ...

The Department of Justice (DOJ) released its annual False Claims Act (FCA) enforcement statistics on January 15, 2025, ...

Christine Kavanagh made the heartbreaking plea after losing her third child to drugs in just four years ... She said: "It's not fair for the mom, the dad, the sisters and brothers to bury another ...

The Laken Riley Act was approved by the Republican-held House last year, but was not taken up at the time in the Democratic-controlled Senate. It passed with bipartisan support on Wednesday only ...

Stimulant medications are considered the first-line treatment for ADHD for some very good reasons. Here are 6 things to know about stimulant medications in ADHD. Attention Deficit Hyperactivity ...

Across the 14 studies included in the data crunch, most of which came from the US, researchers identified dozens of medications that could be linked to the risk of dementia – for better or worse. The ...

Wonder Land: Donald Trump used to be accused of breaking norms. Now it’s ‘disruption.’ Question is: will this approach work in 2025? The answer doesn’t break easily into yes or no. Photo ...

Share on Pinterest GLP-1 drugs may improve brain and heart health but could cause problems for the kidneys and pancreas, according to a new study. FreshSplash/Getty Images Researchers report that ...

Improvements seem related reductions in fat and inflammation Al-Aly said when he looks at his results, he thinks the drugs probably act via two different pathways. One relates to the reduction in ...

"Interestingly, GLP-1RA drugs act on receptors that are expressed in brain areas involved in impulse control, reward and addiction—potentially explaining their effectiveness in curbing appetite ...

Because GLP-1 drugs act on brain regions involved in reward and impulse control, he adds, they might help to reduce cravings for tobacco, alcohol, cannabis and opioids. But the study found risks ...

"Interestingly, GLP-1RA drugs act on receptors that are expressed in brain areas involved in impulse control, reward and addiction - potentially explaining their effectiveness in curbing appetite ...